From the editor's desk
Hemp world takes steps toward legitimacy, but still has need for growth
The hemp and CBD industry seems to be taking a step toward ‘adulthood,’ based on a visit to a recent expo.
Archives for April 5, 2019
Rice Bran Technologies announces acquisitions, sales increase
Rice Bran Technologies has expanded its grain milling capability as the company seems to be turning a corner on sale for its rice bran derivatives.
‘A perfect fit’: Golden Omega acquires OmegaTri
Chilean omega-3 concentrates manufacturer Golden Omega has acquired OmegaTri AS, the Norwegian developer of an innovative omega-3 compressible powder technology.
Company setting hemp commodity prices via proprietary platform
Setting firm commodity prices will be one brick in the wall of a fully legitimized hemp industry. One company has set about doing so with a proprietary trading platform.
April new product launches: Synbiotic supplement for skin, chewable multis, and more
This time of year tends to get a plethora of product launches as brands time their announcements around the Natural Products Expo West show. This year we saw plenty of CBD, beauty-positioning, and as always, protein. Here’s a short list of product...
Animal-sources to drive LATAM's burgeoning protein ingredients market
Soy and pea are seeing increased demand in Latin America's protein ingredients market but it will be animal-sourced variants like whey and beef collagen fueling future growth, says Grand View Research.
Beyond fat and sugar: Diets low in whole grains, fruit and nuts associated with 1 in 5 deaths
A suboptimal diet lacking in whole grains, fruit, nuts and seeds, vegetables and omega-3 fatty acids is responsible for more deaths than any other risk factors globally, according to findings published in The Lancet.
Meta-analysis links vitamins and carotenoids with lower risk of age-related cataract
Higher consumption of certain vitamins and carotenoids is associated with a significantly decreased risk for age-related cataract (ARC), according to a new meta-analysis.
Chr. Hansen lends its microbiome knowhow in Lonza biotherapeutics deal
Chr. Hansen applies its microbiome expertise in the pharma arena as the firm enters a collaboration with Lonza to produce live biotherapeutic (LBP) products that address a range of gastrointestinal and cardiovascular conditions.
Industry expert warns of dwindling natural resources and importance of clinically validated by-products for NPD
Wastage minimisation, standardisation of herbal extracts, and catering to niche market segments are vital to longevity in APAC's nutraceutical market, according to a long-standing R&D expert.
Extracts attack: Pure plant matter key to botanical success, insists Aussie manufacturer
Pure plant matter should be prioritised over botanical extracts if herbal supplement makers hope to achieve longevity in the industry, according to one industry player which is seeing its wholly plant-based supplements business soar
Editor's Spotlight
China Focus: 'Postbiotics', anti-hangover drinks, baby food and our Healthy Ageing APAC Summit
Get the latest news on 'postbiotics', beverage innovations, Australian firms' continued interest in China, and our Healthy Ageing APAC Summit speaker line-up in our newest China round-up.